Discover more insights into Refractory Classic

Keywords frequently search together with Refractory Classic

Narrow sentence examples with built-in keyword filters

Refractory Classic sentence examples within lymphoma r r



Effectiveness of brentuximab vedotin monotherapy in relapsed or refractory Hodgkin lymphoma: a systematic review and meta-analysis.



Salvage therapies in transplant-eligible relapsed classic Hodgkin lymphoma, are novel regimens better?


Refractory Classic sentence examples within programmed death 1



Addition of Low-Dose Decitabine to Anti-PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin Lymphoma.



Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study.


Refractory Classic sentence examples within high dose chemotherapy



Radiotherapy in combination with nivolumab for relapsed/refractory classical Hodgkin lymphoma: About two cases.



Nivolumab for the treatment of relapsed and refractory classical Hodgkin lymphoma after ASCT and in ASCT-naïve patients



Learn more from Refractory Classic


Refractory Classic sentence examples within stem cell transplantation



Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study.



PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation.


Refractory Classic sentence examples within autologous stem cell



Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: a Fondazione Italiana Linfomi real-life experience.



A retrospective study of efficacy and safety of mechlorethamine, vindesine, liposomal doxorubicin, and prednisone (MODP) in relapsed/refractory classical Hodgkin lymphoma.


Refractory Classic sentence examples within Medically Refractory Classic



MRI Texture Analysis Reveals Brain Abnormalities in Medically Refractory Trigeminal Neuralgia



Pre-operative limbic system functional connectivity distinguishes responders from non-responders to surgical treatment for trigeminal neuralgia


Refractory Classic sentence examples within refractory classic hodgkin



A novel scoring system for TIGIT expression in classic Hodgkin lymphoma



Integrating Novel Agents into the Treatment of Classic Hodgkin Lymphoma


More Refractory Classic sentence examples
10.1007/s40265-021-01628-5

Zimberelimab: First Approval


More Refractory Classic sentence examples
10.1038/s41598-021-86655-8

A novel scoring system for TIGIT expression in classic Hodgkin lymphoma


More Refractory Classic sentence examples
10.1016/S2152-2650(21)01251-9

Integrating Novel Agents into the Treatment of Classic Hodgkin Lymphoma


More Refractory Classic sentence examples
10.1200/JCO.2021.39.15_SUPPL.E19515

Safety and efficacy of chidamide in combination with decitabine plus anti-PD-1 camrelizumab after relapse or progression on decitabine-plus-camrelizumab in classical Hodgkin lymphoma.


More Refractory Classic sentence examples
10.1158/1078-0432.CCR-21-0133

Efficacy of Decitabine plus Anti-PD-1 Camrelizumab in Patients with Hodgkin Lymphoma Who Progressed or Relapsed after PD-1 Blockade Monotherapy


More Refractory Classic sentence examples
10.21320/2500-2139-2021-14-1-53-62

Checkpoint Inhibitors and Classical Hodgkin’s Lymphoma: Efficacy and Safety of Pembrolizumab in Relapsed/Refractory Tumor (Experience at the NI Pirogov Russian National Medical Center of Surgery)


More Refractory Classic sentence examples
10.1038/s41375-021-01193-6

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma


More Refractory Classic sentence examples
10.1016/S2352-3026(21)00103-4

Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study.



Checkpoint Inhibition Therapy in Transplant-Ineligible Relapsed or Refractory Classic Hodgkin Lymphoma.


More Refractory Classic sentence examples
10.3389/fphar.2021.733890

Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies


More Refractory Classic sentence examples
10.12998/wjcc.v9.i21.6041

Relapsed/refractory classical Hodgkin lymphoma effectively treated with low-dose decitabine plus tislelizumab: A case report


More Refractory Classic sentence examples
10.1038/s41375-021-01167-8

Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab



Effects of PD-1 blockade on ovarian follicles in a prepubertal female mouse.



Camrelizumab monotherapy leading to partial remission for relapsed upper tract urothelial carcinoma after radical nephroureterectomy: a case report.


More Refractory Classic sentence examples
10.2174/1574892816666210208231744

Current Status and Prospects of Camrelizumab, A Humanized Antibody Against Programmed Cell Death Receptor 1.


More Refractory Classic sentence examples
10.1016/S1470-2045(21)00005-X

Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study.



Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results.



Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphoma


More Refractory Classic sentence examples
10.1007/s11899-021-00604-w

A New Target for Hodgkin Lymphoma - Camidanlumab Tesirine


More Refractory Classic sentence examples
10.1007/s40273-019-00792-7

Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal



Relapsed and Refractory Classical Hodgkin Lymphoma: Keeping Pace With Novel Agents and New Options for Salvage Therapy.


More Refractory Classic sentence examples
10.1080/10428194.2019.1602262

Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma


More Refractory Classic sentence examples
10.1080/10428194.2019.1632446

Experts on their own experiences: the rise of patient-reported outcomes in oncology drug trials


More Refractory Classic sentence examples
10.1007/s40265-019-01167-0

Camrelizumab: First Global Approval


More Refractory Classic sentence examples
10.1016/S2352-3026(18)30192-3

Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial.


More Refractory Classic sentence examples
10.1016/J.NRLENG.2019.03.002

Predictive value of magnetic resonance imaging for identifying neurovascular compressions in trigeminal neuralgia


More Refractory Classic sentence examples
10.3324/haematol.2018.196899

Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study


More Refractory Classic sentence examples
10.1016/J.BBMT.2018.12.815

Impact of Time to Collection from Last Chemotherapy on Autologous Hematopoietic Stem Cell Transplant Outcome for Relapsed/Refractory Classical Hodgkin Lymphoma



Neurovascular Relations of the Trigeminal Nerve in Asymptomatic Individuals Studied with High‐Resolution Three‐Dimensional Magnetic Resonance Imaging


More Refractory Classic sentence examples
10.1158/1538-7445.AM2019-2383

Abstract 2383: The molecular binding mechanism of tislelizumab, an investigational anti-PD-1 antibody, is differentiated from pembrolizumab and nivolumab


More Refractory Classic sentence examples
10.1016/S1470-2045(19)30671-0

Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial.



Erratum



SUN-174 Severe Insulin Resistance and Diabetic Ketoacidosis after Brentuximab Vendotin and Cyclosporin Treatment


More Refractory Classic sentence examples
10.17650/1818-8346-2019-13-4-17-26

Эффективность и безопасность ниволумаба в лечении рецидивирующей и рефрактерной классической лимфомы Ходжкина: опыт ПСПбГМУ им. акад. И. П. Павлова


Learn more from Refractory Classic


Refractory Classic
Encyclopedia
contact@academic-accelerator.com